OncoCyte Corp License Agreements
4 Contracts & Agreements
- Amended and Restated Exclusive License Agreement, effective February 15, 2018, between Razor Genomics, Inc. and the licensor named therein (Filed With SEC on March 19, 2021)
- Second Amendment to License Agreement, dated January 25, 2016, between OncoCyte Corporation and The Wistar Institute of Anatomy and Biology (Filed With SEC on August 11, 2016)
- First Amendment to License Agreement, dated January 25, 2016, between OncoCyte Corporation and The Wistar Institute of Anatomy and Biology (Filed With SEC on March 30, 2016)
- License Agreement, dated January 22, 2016, between OncoCyte Corporation and The Wistar Institute of Anatomy and Biology (Portions of this exhibit have been omitted pursuant to a... (Filed With SEC on March 30, 2016)
